Abstract
The present disclosure provides antibodies and polypeptides that specifically bind to lymphocyte antigen 6 family member K (LY6K). Also provided are compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Full Text
What is claimed is:
The present disclosure provides antibodies and polypeptides that specifically bind to lymphocyte antigen 6 family member K (LY6K). Also provided are compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Timeline
Filed
03/09/2026Published
07/09/2026Granted
Not AvailableIPC Codes(4)
C07K 16/32:against translation products from oncogenes
A61K 47/68:the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61P 35/00:Antineoplastic agents